tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PLUR Stock Latest News

BrainStorm signs LOI with Minaris to manufacture NurOwn
The FlyBrainStorm signs LOI with Minaris to manufacture NurOwn
2d ago
BCLI
PLUR
Pluri CEO issues letter to shareholders
PremiumThe Fly
Pluri CEO issues letter to shareholders
14d ago
PLUR
Pluri Regains Nasdaq Compliance Before Deadline
PremiumCompany Announcements
Pluri Regains Nasdaq Compliance Before Deadline
21d ago
8K
PLUR
Pluri completes strategic acquisition of 71% of equity of Kokomodo for $4.5M
PremiumThe Fly
Pluri completes strategic acquisition of 71% of equity of Kokomodo for $4.5M
1M ago
PLUR
Pluri announces USPTO issued patent covering its immune cell expansion tech
PremiumThe Fly
Pluri announces USPTO issued patent covering its immune cell expansion tech
2M ago
PLUR
Pluri announces exclusive collaboration agreement with Hemafund
PremiumThe FlyPluri announces exclusive collaboration agreement with Hemafund
3M ago
PLUR
EAF and Buhler announce collaboration
Premium
The Fly
EAF and Buhler announce collaboration
3M ago
PLUR
Pluri Announces Strategic Merger to Enhance Market Position
Premium
Company Announcements
Pluri Announces Strategic Merger to Enhance Market Position
3M ago
PLUR
Pluri Proposes Extension of Convertible Bond Maturity to Key Investor
PremiumCompany Announcements
Pluri Proposes Extension of Convertible Bond Maturity to Key Investor
4M ago
PLUR
Pluri Inc. Faces Financial Challenges Amid Continued Innovation
PremiumCompany Announcements
Pluri Inc. Faces Financial Challenges Amid Continued Innovation
4M ago
PLUR
Pluri Ltd. Strengthens Financial Position Through Capital Raising
PremiumCompany Announcements
Pluri Ltd. Strengthens Financial Position Through Capital Raising
4M ago
PLUR
Pluri secures additional $3.5M investment from Merchant Adventure Fund
PremiumThe Fly
Pluri secures additional $3.5M investment from Merchant Adventure Fund
4M ago
PLUR
Pluri Strengthens Leadership Amid Strategic Board Appointment
PremiumCompany AnnouncementsPluri Strengthens Leadership Amid Strategic Board Appointment
4M ago
8K
PLUR
Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market
Premium
The Fly
Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market
4M ago
PLUR
Pluri secures $6.5M investment, acquires 71% stake in Kokomodo for $4.5M
Premium
The Fly
Pluri secures $6.5M investment, acquires 71% stake in Kokomodo for $4.5M
4M ago
PLUR
Pluri congratulates Mesoblast, CEO on FDA approval of MSC-based therapy
PremiumThe Fly
Pluri congratulates Mesoblast, CEO on FDA approval of MSC-based therapy
5M ago
PLUR
Pluri assesses readiness to mass produce PLX-R18
PremiumThe Fly
Pluri assesses readiness to mass produce PLX-R18
6M ago
PLUR
BrainStorm enters MOU with Pluri to support NurOwn trial
PremiumThe Fly
BrainStorm enters MOU with Pluri to support NurOwn trial
7M ago
BCLI
PLUR
Pluri collaborates with Bar-Ilan University to advance cancer immunotherapy
PremiumThe Fly
Pluri collaborates with Bar-Ilan University to advance cancer immunotherapy
7M ago
PLUR
Three new option listings and eighteen option delistings on September 23rd
PremiumThe FlyThree new option listings and eighteen option delistings on September 23rd
8M ago
BFI
TPL
Pluri trading resumes
Premium
The Fly
Pluri trading resumes
10M ago
PLUR
Pluri trading halted, volatility trading pause
Premium
The Fly
Pluri trading halted, volatility trading pause
10M ago
PLUR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >